LabGenius uses Graphcore's IPUs to speed up drug discovery

AI-driven scientific research firm LabGenius is harnessing the power of Graphcore's IPUs (Intelligence Processing Units) to speed up its drug discovery efforts. LabGenius is currently focused on discovering new treatments for cancer and inflammatory diseases. The firm combines AI, lab automation, and synthetic biology for its potentially life-saving work. Until now, the company has been using traditional GPUs for its workloads. LabGenius reports that switching to Graphcore's IPUs in cloud instances from Cirrascale Cloud Services enabled its training of models to be reduced from one month to around two weeks.